1)日本透析医学会 : 2015年版慢性腎臓病患者における腎性貧血治療のガイドライン.日透析医会誌49 : 89-158, 2016
2)Sofue T, et al : Prevalence of anemia in patients with chronic kidney disease in Japan : a nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database(J-CKD-DB). PLoS One 15 : e0236132, 2020
3)Coyne DW, et al : New options for the anemia of chronic kidney disease. Kidney Int Suppl 7 : 157-163, 2017
4)Fukuma S, et al : Erythropoiesis-stimulating agent responsiveness and mortality in hemodialysis patients : results from a cohort study from the dialysis registry in Japan. Am J Kidney Dis 59 : 108-116, 2012
5)Evans M, et al : Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease : a nationwide analysis. Clin Kidney J 13 : 821-827, 2020
6)Narita I, et al : Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients : The BRIGHTEN study. PLoS One 17 : e0277921, 2022
7)日本腎臓学会 : HIF-PH阻害薬適正使用に関するrecommendation.日腎会誌62 : 711-716, 2020